Influence of chemical allograft preservation procedures on the human immunodeficiency virus

Laryngoscope

Volumn 106, Issue 5, 1996, Pages 645-647

  Bujía, Jesús ^a   Wilmes, Eberhard ^a   Kastenbauer, Ernst ^a   Gürtler, Lutz ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CADAVER DONOR; GRAFT PRESERVATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFECTION RISK; PRIORITY JOURNAL; SCREENING; VIRUS DETECTION; VIRUS TRANSMISSION;

BASE SEQUENCE; BLOOD; BRAIN; CARTILAGE; CIALIT; CONNECTIVE TISSUE; FORMALDEHYDE; HIV; HIV INFECTIONS; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; SPLEEN; THIMEROSAL; TISSUE PRESERVATION; TRACHEA; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029929498     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1097/00005537-199605000-00024     Document Type: Article

References (28)

1. Kastenbauer ER. Konservierung und Anwendungsmöglich-keiten allogener (homologer) Transplantate im Hals-Nasen-Ohrenbereich. HNO. 1983;31:371-380.
2. Martin LS, Loskosi SL, McDougal JS. Inactivation of human T-lymphotropic virus type III/lymphadenopathy-associated virus by formaldehyde-based reagents. Appl Environ Microbiol. 1987;53:708-709.
3. Murphey-Corb M, Martin CM, Davison-Fairburn B, et al. A formaline-inactivated whole SIV vaccine confers protectium in macaques. Science. 1989;1293-1297.
4. Spire B, Barre Sinoussi F, Montagnier L, et al. Inactivation of lymphadenopathy associated virus by chemical disinfectants. Lancet. 1984;2:899-901.
5. Röder W, Müller W, Merz H. Ist Cialit zur HIV-Abtötung geeignet?. Dtsch Ärztebl. 1991;88:2416.
6. Wilmes E, Gürtler L, Wolf H. ZurÜbertragbarkeit von HIV-Infektionen durch allogene Transplantate. Laryngol Rhinol Otol. 1987;66:332-334.
7. Laskin DM, Sarnat BG. The metabolism of fresh, transplanted and preserved cartilage. Surg Gynecol Obstet. 1953;96:493.
8. Marquardt P. Arzneimittelforschung. 1954;8:481.
9. Perkins R. Human homograft otologic tissue transplantation buffered formaldehyde preparation. Trans Am Acad Ophtalmol Otolaryngol. 1970;74:278-282.
10. Mueller AJ, KLAUSS V, Gürtler L, et al. Infrequent detection of HIV-1 components in tears compared to blood of HIV-1-infected persons. Infection. 1992;20:249-252.
11. Kellog DE, Kwok S. Detection of human immunodeficiency virus. In: Innis MA, Gelfands DH, Sninsky JJ, White TJ, eds. PCR Protocols: A Guide to Methods and Application. San Diego: Academic Press, 1980:337-347.
12. Ottmann M, Innocenti P, Thenadey M, et al. The polymerase chain reaction for the detection of HIV-1 genomic RNA in plasma from infected individuals. J Virol Methods. 1991;31:273-284.
13. Williams P, Simmons P, Yap PL, et al. The polymerase chain reaction in the diagnosis of vertically transmitted HIV infection. AIDS. 1990;4:393-398.
14. Bernoulli C, Siegfried J, Baumgartner G, et al. Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet. 1977;1:478-479.
15. Brown P, Gibbs JC, Gajdusek DC, et al. Transmission of Creutzfeldt-Jacob disease from formaline paraffin-embedded human brain tissue. N Engl J Med. 1986;315:1614-1615.
16. Davampour DVM, Alter M, Sobel E, et al. Creutzfeldt-Jakob discase: possible medical risk factors. Neurology. 1985;35:1483-1486.
17. Prompt CA, Reis MM, Grillo FM, et al. Transmission of AIDS virus at renal transplantation. Lancet. 1985;2:672.
18. Stewart GJ, Cunningham AL, Driscoll GL, et al. Transmission of human-T-cell lymphotropic virus type III (HTLV-III) by artificial insemination by donor. Lancet. 1985;2:581-584.
19. Fox CH, Cottler-Fox M. The pathobiology of HIV infection. Imunol Today. 1992;13:353-356.
20. Bujía J, Pitzke P, Wilmes E, et al. Possibilities of human immunodeficiency virus transmission using cartilage allografts. Eur Arch Otorhinolaryngol. 1993;250:55-58.
21. Bujía J, Meyer H, Hammer C, et al. Human immunodeficiency virus cannot productively infect freshly cultured human cartilage cells. ORL J Otorhinolaryngol Relat Spec. 1993;55:222-225.
22. Bujía J, Zietz C, Randolph P, et al. Absence of HIV-1 in cartilage tissue from HIV-positive patients. Eur Arch Otolaryngol. 1994;251: 347-349.
23. Marquet JFE. La philosophie du traitement de l'otite chronique. Acta Otorhinolaryngol Belg. 1966;62:459-464.
24. Hagerty RF, Calhoon TB. Human cartilage grafts stored in merthiolate. Surg Gynecol Obstet. 1960;110:229-233.
25. Bujía J, Wilmes E, Hammer C, et al. A comparison of class II antigenicity of human tracheal allografts stored in Cialit and in Merthiolate. Laryngoscope. 1990;100:1337-1340.
26. Herberhold C, Franz B, Breipohl W. Chemisch-konservierte menschliche Trachea als Prothesenmaterial zur Deckung trachealer Defekte. Laryngol Rhinol Otol. 1980;59:453-457.
27. Martin LS, McBougal JS, Loskoski SI. Disinfection and inactivation of the human T-lymphotropic virus type III/lymphadenopathy-associated virus. J Infect Dis. 1985;152:400-403.
28. Knaepler H, Koch F, Bugany H. Untersuchungen zur HIV-Inaktivierung in allogenen Knochentransplantaten durch chemische Desinfektion und radioaktive Bestrahlung. Unfallchirurg. 1992;18:1-6.